Recipharm, Strängnäs, Södermanland, Pharmaceuticals, Quality Assurance
Hays is recruiting a Quality Assurance Officer for our client Recipharm in Strängnäs. This is a permanent position, we are evaluating applications continuously so apply today if you are interested in the position.
Recipharm Strängnäs is a dedicated penicillin (Beta-lactams) manufacturing facility manufacturing tablets, granulates and minitablets in a variety of finished packed forms. Recipharm Strängnäs currently holds a License from LV for the manufacturing and packaging of authorized medicinal products and clinical trial products. The Quality Assurance officer provides general support in all aspects of the development and maintenance of the Quality Management System supporting; clinical trial manufacture, routine manufacture and analysis of antibiotics. This hands-on QA role is focused on supporting manufacturing and supply chain operations, facilitating their effective compliance with GMP.
The role consists of:
The candidate should:
Experience with LIMS, M3 (ERP), Seavision & Tracelink is not essential but beneficial.
The opportunity to further educational requirements to attain QP status is a potential scope for development within the role depending on development within the QA structures.
Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 6,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm's turnover is approximately SEK 6 billion and the Company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm. For more information on Recipharm and our services, please visit www.recipharm.com